HomeCompareFNCSF vs MRK

FNCSF vs MRK: Dividend Comparison 2026

FNCSF yields 16.94% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FNCSF wins by $17412864.48M in total portfolio value
10 years
FNCSF
FNCSF
● Live price
16.94%
Share price
$5.81
Annual div
$0.98
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$17412864.54M
Annual income
$17,217,589,352,950.68
Full FNCSF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — FNCSF vs MRK

📍 FNCSF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFNCSFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FNCSF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FNCSF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FNCSF
Annual income on $10K today (after 15% tax)
$1,439.73/yr
After 10yr DRIP, annual income (after tax)
$14,634,950,950,008.08/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, FNCSF beats the other by $14,634,950,941,679.67/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FNCSF + MRK for your $10,000?

FNCSF: 50%MRK: 50%
100% MRK50/50100% FNCSF
Portfolio after 10yr
$8706432.30M
Annual income
$8,608,794,681,374.41/yr
Blended yield
98.88%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

FNCSF
No analyst data
Altman Z
3.0
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FNCSF buys
0
MRK buys
0
No recent congressional trades found for FNCSF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFNCSFMRK
Forward yield16.94%2.76%
Annual dividend / share$0.98$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$17412864.54M$56.8K
Annual income after 10y$17,217,589,352,950.68$9,798.13
Total dividends collected$17399832.19M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FNCSF vs MRK ($10,000, DRIP)

YearFNCSF PortfolioFNCSF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$14,088$3,387.61$11,206$366.19+$2.9KFNCSF
2$23,994$8,920.24$12,650$502.35+$11.3KFNCSF
3$54,072$28,398.01$14,407$694.19+$39.7KFNCSF
4$177,476$119,619.14$16,585$967.82+$160.9KFNCSF
5$923,765$733,866.23$19,342$1,363.89+$904.4KFNCSF
6$8,128,225$7,139,796.00$22,913$1,947.19+$8.11MFNCSF
7$126,123,699$117,426,498.23$27,662$2,823.89+$126.10MFNCSF
8$3,540,706,705$3,405,754,346.82$34,159$4,173.35+$3540.67MFNCSF
9$182,500,176,413$178,711,620,239.43$43,337$6,308.80+$182500.13MFNCSF
10$17,412,864,541,713$17,217,589,352,950.68$56,776$9,798.13+$17412864.48MFNCSF

FNCSF vs MRK: Complete Analysis 2026

FNCSFStock

North American Financial 15 Split Corp. is an equity mutual fund launched by Quadravest Inc. It is managed by Quadravest Capital Management Inc. The fund invests in public equity markets of United States and Canada. It invests in high quality portfolio of preferred shares and Class A shares of 15 financial services companies. The fund employs investment strategy along with fundamental based equity investing with covered call writing to create its portfolio. It was formerly known as Financial 15 Split Corp. II. North American Financial 15 Split Corp. was formed on October 15, 2004 and is domiciled in Canada.

Full FNCSF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this FNCSF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FNCSF vs SCHDFNCSF vs JEPIFNCSF vs OFNCSF vs KOFNCSF vs MAINFNCSF vs JNJFNCSF vs ABBVFNCSF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.